Electrophysiology experiments in ME/CFS patients reported a potential benefit in restoring impaired TRPM3 ion channel activity following treatment of isolated NK cells with NTX [25]. The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.